Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2026 Filed Jul 13, 2026 21:06 UTC |
Valentine KeithDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 24,826 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001213900-26-077634 · ownership.xml · derivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,826 Underlying: Ordinary Shares · 24,826 shares Expires 2036-05-28 F1 · security: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2 · security: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 21:05 UTC |
GELLER EHUDDirector · Chief Executive Officer
|
GrantWarrants to purchase ordinary shares · Derivative | 31,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-077631 · ownership.xml · derivative · entry 1 GELLER EHUD · CIK 0001284386 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,250 Underlying: Ordinary Shares · 31,250 shares Expires 2029-02-23 F1 · security: This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2 · security: The warrants are currently exercisable and have a three year term. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 21:07 UTC |
Alpert Susan PHD MDDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 24,826 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001213900-26-077638 · ownership.xml · derivative · entry 1 Alpert Susan PHD MD · CIK 0001204668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,826 Underlying: Ordinary Shares · 24,826 shares Expires 2036-06-04 F1 · security: This option grant was approved by the Board of Directors of the Issuer on June 4, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2 · security: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on September 4, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or June 4, 2029. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 21:06 UTC |
Dykan JeffDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 24,826 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001213900-26-077633 · ownership.xml · derivative · entry 2 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,826 Underlying: Ordinary Shares · 24,826 shares Expires 2036-05-28 F3 · security: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F4 · security: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029. F5 · security: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 21:06 UTC |
Dykan JeffDirector
|
GrantWarrants to purchase ordinary shares · Derivative | 12,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-077633 · ownership.xml · derivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Ordinary Shares · 12,500 shares Expires 2029-02-23 F1 · security: This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2 · security: The warrants are currently exercisable and have a three year term. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 21:07 UTC |
Ben-Elazar PiniDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,313 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-077636 · ownership.xml · derivative · entry 2 Ben-Elazar Pini · CIK 0002114839 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,313 Underlying: Ordinary Shares · 8,313 shares Expires 2036-02-23 F3 · security: This option grant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F4 · security: This option grant is fully vested as of this date. F5 · security: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 21:07 UTC |
Ben-Elazar PiniDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 24,826 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001213900-26-077636 · ownership.xml · derivative · entry 1 Ben-Elazar Pini · CIK 0002114839 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,826 Underlying: Ordinary Shares · 24,826 shares Expires 2036-06-04 F1 · security: This option grant was approved by the Board of Directors of the Issuer on June 4, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2 · security: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on September 4, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or June 4, 2029. F5 · security: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 21:01 UTC |
Cohen-Arazi EfraimDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 24,826 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001213900-26-077622 · ownership.xml · derivative · entry 1 Cohen-Arazi Efraim · CIK 0002114591 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,826 Underlying: Ordinary Shares · 24,826 shares Expires 2036-05-28 F1 · security: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2 · security: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029. F3 · security: . To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.